Intelligence · Clinical Development
Pipeline search results
Programs matching “oncology” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 189 pipeline programs matching "oncology" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Tipifarnib
Kura Oncology
Myelodysplastic Syndromes
1 trial -
Tipifarnib
Kura Oncology
HNSCC
1 trial -
Tipifarnib
Kura Oncology
Thyroid Cancer
1 trial -
Tipifarnib
Kura Oncology
Relapsed or Refractory Peripheral T-Cell Lymphoma
1 trial -
Toripalimab
Coherus Oncology
Localized Colon Carcinoma
1 trial -
Toripalimab
Coherus Oncology
Sinonasal Cancer
1 trial -
Toripalimab
Coherus Oncology
Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M)
1 trial -
Toripalimab + Chemotherapy
Coherus Oncology
Head and Neck Cancer
1 trial -
Toripalimab-tpzi
Coherus Oncology
Squamous Cell Carcinoma
1 trial -
Tyenne 162 mg solution for injection in pre-filled pen
Cardiff Oncology
Psoriatic Arthritis, Rheumatoid Arthritis
1 trial -
Tyenne 162 mg solution for injection in pre-filled pen
Cardiff Oncology
Psoriatic Arthritis, Rheumatoid Arthritis
1 trial -
VT30
BridgeBio Oncology Therapeutics
Venous Malformation
1 trial -
Vancomycin
Cardiff Oncology
Late Onset Neonatal Sepsis
1 trial -
Zanidatamab
ALX ONCOLOGY HOLDINGS INC
HER2-expressing Cancers
1 trial -
Ziftomenib
Kura Oncology
Advanced Malignant Neoplasm
1 trial -
Ziftomenib, Ziftomenib
Kura Oncology
Relapsed and/or refractory Acute Myeloid Leukemia
1 trial -
capecitabine
Cardiff Oncology
Pancreatic Cancer
1 trial -
carboplatin
Cardiff Oncology
Bladder Cancer
1 trial -
cisplatin
Cardiff Oncology
Bladder Cancer
2 trials -
encaleret
BridgeBio Oncology Therapeutics
Post-Surgical Hypoparathyroidism
1 trial -
evorpacept
ALX ONCOLOGY HOLDINGS INC
Head and Neck Cancer
2 trials -
oncolytic adenovirus expressing GMCSF
CG Oncology
Bladder Cancer
1 trial -
sirolimus
Cardiff Oncology
Tuberous Sclerosis
1 trial -
AG10 oral tablet
BridgeBio Oncology Therapeutics
Amyloid Cardiomyopathy, Transthyretin-Related
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.